20 NATIONAL GROWTHFUND PROGRAMS HELP STIMULATE INNOVATION There are several National Growth Fund programs that fit the mission and vision of HAN BioCentre and its research groups. Because of that, they are strongly connected to HAN BioCentre in building national networks to stimulate innovation in the Netherlands. BIOTECH BOOSTER Biotech Booster is a national program funded by the Dutch National Growth Fund that supports the commercialization of biotechnology findings in the Netherlands. Biotech Booster provides financial support, mentorship, and networking opportunities to guide scientists and entrepreneurs from the idea stage to a viable or commercial proposition. The goal is to ensure that the benefits of biotechnology have a more significant and faster impact on society. Moreover, Biotech Booster facilitates close collaborations between public and private partners in the biotechnology sector and established 5 Thematic Clusters following biotechnological focus areas: • White: Industrial Biotechnology & Production (TC 1) • Green: Agriculture & Food (TC 2) • Red: ATMP’s, Biopharmaceuticals & Associated Enabling Technologies (TC 3) • Red: Diagnostics & Services (TC 4) • Red: Vaccines, Small Molecules, Discovery & Development Platforms (TC 5) At HAN BioCentre one of Biotech Booster’s Impact Developers of Industrial Biotechnology & Production is stationed (Bob Ignacio). biotechbooster.nl PHARMANL Pharmaceutical innovation holds immense societal value. Medicines contribute significantly to improving the quality of life in our society. It is therefore crucial to ensure that the development of innovative medicines, from the initial phase to actual production, proceeds as efficiently and effectively as possible. The PharmaNL program is an initiative by and for the Dutch pharmaceutical sector. It is a national public- private consortium consisting of Leiden University, Campus Groningen, Pivot Park, in close collaboration with FAST (Centre for Future Affordable Sustainable Therapy Development). HAN BioCentre, research group Drug Discovery and the Life Long Learning team of HAN are strongly connected to this growth fund, for example by developing courses and post-graduate education for professionals working in the pharmaceutical sector. PharmaNL aims to strengthen the pharmaceutical value chain within the Netherlands and address bottlenecks, specifically by: • Creating a shared infrastructure for the development, scaling, and production of innovative medicines in the Netherlands, for use by pharmaceutical start-ups, scale-ups, and academic research groups. • Enhancing the pharmaceutical education offerings with international appeal and attractiveness. pharmanl.org
RkJQdWJsaXNoZXIy ODY1MjQ=